Cell-based assays market.
LONDON, U.K., November 12, 2015 - The global cell-based assays market is expected to reach $18 million by 2020 from $11 million in 2015, growing at a CAGR of 11 percent between 2015 and 2020, according to a report.
The product segments included in this report are consumables, instruments, services and software.
The consumables segment is further segmented into reagents and assay kits, cell lines, and micro plates. Reagents and assay kits include reporter gene assays, second messenger assays, cell growth assays, cell death assays and other assays.
Cell lines include immortalized cell lines, primary cell lines and stem cell lines.
Applications include basic research, drug discovery, predictive toxicology, ADME studies and other applications.
Drug discovery had the largest share of the market in 2015. Predictive toxicology is expected to be one of the fastest growing applications between 2015 and 2020.
The report covers North America, Europe, Asia and the rest of the world (RoW). North America accounted for the largest share in the market in 2015. Asia is expected to register a faster growth from 2015 to 2020.
The key driver for this market is increased R&D spending on research. Furthermore, growing benefits of cell-based assays over other methods, their increasing adoption in drug discovery, and advancements in automation and high-throughput techniques will aid market growth.
"Cell-based Assays Market by Product, Applications, End User, & Region - Global Forecast to
2020," November 2015, MarketsandMarkets, 178 pages, $4,650.